Successful treatment of orthopneumovirus infection in a patient with primary diffuse B-cell large cell lymphoma of the central nervous system
- 7 April 2026
- journal article
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 71 (1)
Abstract
Introduction . Oncohematological patients are a vulnerable category in relation to orthopneumovirus (OPV), which affects cells of the respiratory epithelium and lung tissue. Aim: to present a clinical observation of the identification of OPV and successful ribavirin treatment of a patient with Diffuse large B-cell lymphoma (DLBCL) and acute respiratory failure (ARF) due to viral pneumonia. Main findings. Patient S., 56 years old, was diagnosed with DLBCL of the central nervous system. After the first course of chemotherapy, he developed acute kidney injury, fever, and bilateral pneumonia with ARF. DNA of Pneumocystis jirovecii was found in bronchoalveolar lavage (BAL) fluid. Therapy with co-trimoxazole and micafungin had no effect. Repeated examination of the BAL fluid did not reveal the DNA of Pneumocystis jirovecii. An extended virological examination revealed OPV RNA in a nasal smear, and ribavirin was added to the therapy. During the following days, normalization of body temperature was noted for the first time, after 3 days there was a regression of ARF. Thus, ribavirin has been shown to be highly effective in cases of confirmed OPV infection.Keywords
This publication has 16 references indexed in Scilit:
- Presatovir: A Once‐daily Oral Respiratory Syncytial Virus Fusion Inhibitor for the Treatment of Respiratory Syncytial Virus Infection in Adults and Infants2025
- Impact of Respiratory Syncytial Virus (RSV) on adult haematology oncology patientsJournal of Infection, 2024
- Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-AnalysisAdvances in Therapy, 2022
- RESPIRATORY SYNCYTIAL VIRUS IN A PANCYTOPENIC PATIENT WITH LOWER RESPIRATORY TRACT INFECTION: TREAT FIRST, INVESTIGATE LATERChest, 2020
- Viral Respiratory Infections in Hematological PatientsInfectious Diseases and Therapy, 2020
- Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignanciesTransplant Infectious Disease, 2018
- CT-Morphological Characterization of Respiratory Syncytial Virus (RSV) Pneumonia in Immune-Compromised AdultsRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2014
- Epidemiology of viral respiratory tract infections in an outpatient haematology facilityAnnals of Hematology, 2013
- Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the LiteratureClinical Infectious Diseases, 2008
- Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2001